Table 1.
Participants baseline characteristicsa
| Controls (n = 23) | ESRD, non-DM (n = 21) | Pb | |
|---|---|---|---|
| Age (years) | 43 (35, 49) | 46 (40, 52) | 0.39 |
| BMI (kg/m2) | 25.7 (22.1, 28.9) | 27.0 (23.8, 30.7) | 0.36 |
| Height (in) | 67 (64, 71) | 69 (67, 72) | 0.19 |
| Weight (lb) | 163 (144, 186) | 180 (166, 205) | 0.11 |
| Fasting blood sugar (mg/dL) | 87 (81, 92) | 91 (86, 96) | 0.14 |
| Creatinine (mg/dL) | 0.8 (0.7, 0.9) | 7.7 (5.7, 9.6) | <0.01 |
| Ccr (mL/min)d | 118 (109, 142) | 9.5 (8, 15)c | <0.01 |
| Sex (female) | 15 (65%) | 6 (29%) | 0.02 |
| Race | 0.99 | ||
| African-American | 4 (17%) | 4 (19%) | |
| Caucasian | 17 (74%) | 15 (71%) | |
| Other | 2 (9%) | 2 (10%) |
BMI, body mass index; Ccr, creatinine clearance; ESRD, end-stage renal disease.
aMedian (first quartile, third quartile) for continuous data or frequencies (percent) for categorical data.
bWilcoxon test or Fisher's exact test.
cn = 8 computed for ESRD participants that were not yet on dialysis.
dClearance in controls measured by 24 h urine collection, in ESRD participants that were not on dialysis pretransplantation by modification of diet in renal disease equation.